Insider trading

Period: 12 months Stock: HTFL + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

36 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

36 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

36 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

36 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
36 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
36 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

36 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
18 Sep 2026
Rogers Campbell Chief Medical Officer
Sold on a plan
$987.05K 19,682 at 50.15
19.8%
Planned (10b5-1)
18 Sep 2026
Verghese Vikram Chief Financial Officer
Sold on a plan
$850.93K 16,766 at 50.75
9.8%
Planned (10b5-1)
17 Sep 2026
Verghese Vikram Chief Financial Officer
Sold on a plan
$379.82K 7,579 at 50.11
4.2%
Planned (10b5-1)
15 Sep 2026
Verghese Vikram Chief Financial Officer
Sold on a plan
$33.41K 668 at 50.01
0.4%
Planned (10b5-1)
14 Sep 2026
Verghese Vikram Chief Financial Officer
Sold on a plan
$230.74K 4,593 at 50.24
2.5%
Planned (10b5-1)
11 Sep 2026
Verghese Vikram Chief Financial Officer
Sold on a plan
$1.49M 29,714 at 50.06
13.9%
Planned (10b5-1)
11 Sep 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$194.50K 3,890 at 50.00
1.2%
Planned (10b5-1)
10 Sep 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$1.63M 35,010 at 46.42
9.7%
Planned (10b5-1)
8 Sep 2026
Verghese Vikram Chief Financial Officer
Sold on a plan
$332.21K 6,640 at 50.03
3.0%
Planned (10b5-1)
3 Sep 2026
Verghese Vikram Chief Financial Officer
Sold on a plan
$1.37M 27,540 at 49.69
11.1%
Planned (10b5-1)
2 Sep 2026
Verghese Vikram Chief Financial Officer
Sold on a plan
$297.33K 5,876 at 50.60
2.3%
Planned (10b5-1)
21 Aug 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$1.36M 27,230 at 50.00
7.0%
Planned (10b5-1)
18 Aug 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$1.47M 32,676 at 45.00
7.8%
Planned (10b5-1)
17 Aug 2026
Rogers Campbell Chief Medical Officer
Sold on a plan
$380.10K 9,219 at 41.23
9.6%
Planned (10b5-1)
14 Aug 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$607.77K 15,560 at 39.06
3.6%
Planned (10b5-1)
10 Aug 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$638.73K 22,562 at 28.31
4.9%
Planned (10b5-1)
15 Jul 2026
Rogers Campbell Chief Medical Officer
Sold on a plan
$237.11K 9,219 at 25.72
9.4%
Planned (10b5-1)
10 Jul 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$626.10K 22,562 at 27.75
4.9%
Planned (10b5-1)
24 Jun 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$1.36M 38,900 at 35.00
7.8%
Planned (10b5-1)
10 Jun 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$643.02K 22,562 at 28.50
4.3%
Planned (10b5-1)
18 May 2026
Rogers Campbell Chief Medical Officer
Sold on a plan
$261.27K 9,219 at 28.34
10.5%
Planned (10b5-1)
11 May 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$657.01K 22,562 at 29.12
4.2%
Planned (10b5-1)
30 Apr 2026
Sold at will 2×
$27.73M 948,757 at 29.23
10.1%
Not planned
29 Apr 2026
Sold at will
$23.41M 797,133 at 29.37
7.8%
Not planned
28 Apr 2026
Sold at will
$7.75M 254,110 at 30.51
2.4%
Not planned
10 Apr 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$602.86K 22,562 at 26.72
3.9%
Planned (10b5-1)
1 Apr 2026
Rogers Campbell Chief Medical Officer
Sold on a plan
$1.59M 64,533 at 24.64
44.3%
Planned (10b5-1)
19 Mar 2026
Rogers Campbell Chief Medical Officer
Sold on a plan
$1.66M 64,533 at 25.69
45.1%
Planned (10b5-1)
18 Mar 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$243.13K 9,725 at 25.00
1.7%
Planned (10b5-1)
10 Mar 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$290.89K 12,837 at 22.66
2.2%
Planned (10b5-1)
5 Mar 2026
Cullivan Julie A Director
Sold on a plan
$228.05K 9,122 at 25.00
25.1%
Planned (10b5-1)
12 Feb 2026
Rogers Campbell Chief Medical Officer
Sold on a plan
$1.60M 65,153 at 24.49
46.1%
Planned (10b5-1)
10 Feb 2026
Farquhar John C.M. Chief Executive Officer
Sold on a plan
$619.55K 22,562 at 27.46
3.7%
Planned (10b5-1)
5 Feb 2026
Cullivan Julie A Director
Sold on a plan
$218.56K 8,000 at 27.32
18.0%
Planned (10b5-1)
4 Feb 2026
Sold at will
$56.10M 2,000,000 at 28.05
16.1%
Not planned
16 Dec 2025
Bought
$1.05M 40,000 at 26.34
opened
First buy on file
Showing 1–36 of 36.